• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I ANTI-HBS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ALINITY I ANTI-HBS Back to Search Results
Catalog Number 07P89-74
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.An evaluation is in process.A final report will be submitted when the evaluation is complete.This report is being filed on an international product, alinity anti-hbs list 7p89 that has a similar product distributed in the us, list number 7p88.
 
Event Description
The customer obtained a false elevated alinity i anti-hbs result, for a (b)(6) year old male patient with a history of (b)(6) infection.The sample generated a result of >1000 on the alinity and non-reactive on the autobio assay.The customer further indicated the sample was tested on an architect at an alternate lab and generated the same result as the alinity.No impact to patient management was reported.
 
Manufacturer Narrative
No customer returns were available for investigation.The alinity i anti-hbs reagent lot 01009fn00 was evaluated using an in-house retained kit.All specifications were met indicating the lot is performing acceptably.Complaint searches determined normal complaint activity for reagent lot 01009fn00.The complaint trending report review determined that there is no related trends associated with the issue.Manufacturing documentation associated with the reagent lot did not identify any issues.Labeling was reviewed and found to be adequate.Based on all available information no systemic issue or deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY I ANTI-HBS
Type of Device
ANTI-HBS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key9668206
MDR Text Key220246909
Report Number3008344661-2020-00011
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 03/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/18/2020
Device Catalogue Number07P89-74
Device Lot Number01009FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/13/2020
Initial Date FDA Received02/04/2020
Supplement Dates Manufacturer Received03/19/2020
Supplement Dates FDA Received03/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY I PROCESSING MODULE, LIST 03R65-01,; ALINITY I PROCESSING MODULE, LIST 03R65-01,; SERIAL (B)(6) ; SN (B)(6)
Patient Age64 YR
-
-